R Vogler
Overview
Explore the profile of R Vogler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raza A, Yousuf N, Bokhari S, Abbas A, Lampkin B, Pancoast J, et al.
Int J Oncol
. 2011 May;
2(2):301-7.
PMID: 21573555
Prognostic factors were related to remission duration among 179 standard risk newly diagnosed acute myeloid leukemia (AML) patients who received identical induction and consolidation therapies. Following a bromodeoxyuridine infusion, labeling...
2.
Manggau M, Kim D, Ruwisch L, Vogler R, Korting H, Schafer-Korting M, et al.
J Invest Dermatol
. 2001 Nov;
117(5):1241-9.
PMID: 11710939
Owing to its ability to induce growth arrest and differentiation of keratinocytes, 1alpha,25-dihydroxyvitamin D3 and its analogs are useful for the treatment of hyperproliferative skin diseases, such as psoriasis vulgaris....
3.
Liehr P, Vogler R, Meininger J
Adv Pract Nurs Q
. 1998 Feb;
3(2):10-8.
PMID: 9432448
Lifestyle modification is the recommended intervention for stage 1 hypertension. Advanced practice nurses are well positioned to guide lifestyle modification, and they are well prepared to measure outcomes related to...
4.
Berman E, Wiernik P, Vogler R, Velez-Garcia E, Bartolucci A, Whaley F
Cancer
. 1997 Dec;
80(11 Suppl):2181-5.
PMID: 9395031
Background: Most clinical trials for acute leukemia have reported results after 2-3 years of follow-up. Comparisons between the original data and longer-term follow-up data may be of interest, particularly with...
5.
Vogler R, Castillo M
AJNR Am J Neuroradiol
. 1995 Apr;
16(4):773-5.
PMID: 7611037
The imaging features of a cavernous angioma, which originated from the meninges, are presented. The patient harbored a second cavernous angioma within the brain parenchyma. Cavernous angioma should be included...
6.
Goldberg J, Gryn J, Raza A, Bennett J, Browman G, Bryant J, et al.
Am J Hematol
. 1993 Aug;
43(4):286-90.
PMID: 7690519
In an effort to determine if cell cycle active agents are augmented when given after non-cell cycle active agents, 104 patients with either multiply relapsed or refractory acute nonlymphocytic leukemia...
7.
Starck P, Duffy M, Vogler R
J Prof Nurs
. 1993 Jul;
9(4):212-9.
PMID: 8366245
Nursing in the next century will reflect changes in the health care system, and although the profession has made great strides in preparing nurse researchers, the current system has a...
8.
Raza A, Preisler H, Browman G, Larson R, Rustum Y, Goldberg J, et al.
Leuk Lymphoma
. 1993 May;
10(1-2):57-66.
PMID: 8374524
Three successive strategies used to treat acute myelogenous leukemia (AML) patients who entered complete remission are compared with respect to their long term efficacy (> 5 years). Additionally, the ability...
9.
Raza A, Preisler H, Li Y, Larson R, Goldberg J, Browman G, et al.
Am J Hematol
. 1993 Apr;
42(4):359-66.
PMID: 8493986
A pilot study was conducted of the biological characteristics of the leukemia cells of newly diagnosed patients with poor prognosis acute myelogenous leukemia (AML). This study included measurements of the...
10.
Raza A, Gezer S, Anderson J, Lykins J, Bennett J, Browman G, et al.
Exp Hematol
. 1992 Nov;
20(10):1194-200.
PMID: 1426099
Pretherapy bone marrow (BM) aspirates of 143 patients with acute myeloid leukemia (AML) were incubated simultaneously with bromodeoxyuridine (BrdU) and tritiated cytosine arabinoside ([3H]Ara-C) to determine the labeling index (LI)...